Published in Respiration on November 28, 2007
Comorbidities and burden of COPD: a population based case-control study. PLoS One (2013) 1.17
Targeted disruption of NF-{kappa}B1 (p50) augments cigarette smoke-induced lung inflammation and emphysema in mice: a critical role of p50 in chromatin remodeling. Am J Physiol Lung Cell Mol Physiol (2009) 1.09
Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controls. Int J Chron Obstruct Pulmon Dis (2015) 0.96
Chronic obstructive pulmonary disease: a view from the NHLBI. Am J Respir Crit Care Med (2008) 0.95
Xenobiotic particle exposure and microvascular endpoints: a call to arms. Microcirculation (2012) 0.88
Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives. Mediators Inflamm (2010) 0.88
Longer telomere length in COPD patients with α1-antitrypsin deficiency independent of lung function. PLoS One (2014) 0.87
Acute exacerbation of chronic obstructive pulmonary disease: cardiovascular links. Biomed Res Int (2014) 0.85
Utility of the CAT in the therapy assessment of COPD exacerbations in China. BMC Pulm Med (2014) 0.84
Predictive factors of complications after surgical repair of iatrogenic femoral pseudoaneurysms. World J Surg (2011) 0.84
Histone deacetylase activity is decreased in peripheral blood monocytes in patients with COPD. J Inflamm (Lond) (2012) 0.83
The effects of sleep hypoxia on coagulant factors and hepatic inflammation in emphysematous rats. PLoS One (2010) 0.82
Chronic Obstructive Pulmonary Disease is associated with risk of Chronic Kidney Disease: A Nationwide Case-Cohort Study. Sci Rep (2016) 0.82
The unique alterations of hippocampus and cognitive impairment in chronic obstructive pulmonary disease. Respir Res (2013) 0.82
Oxidative stress in chronic obstructive pulmonary disease: a lung and systemic process. Can Respir J (2013) 0.80
Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease. BMC Pulm Med (2013) 0.80
Prediction of cardiovascular events by using non-vascular findings on routine chest CT. PLoS One (2011) 0.79
Obstructive airway disease and edentulism in the atherosclerosis risk in communities (ARIC) study. BMJ Open (2012) 0.79
Alterations in the expression of the NF-κB family member RelB as a novel marker of cardiovascular outcomes during acute exacerbations of chronic obstructive pulmonary disease. PLoS One (2014) 0.78
Survival benefit of CPAP favors hypercapnic patients with the overlap syndrome. Lung (2014) 0.78
Efficacy and safety of eco-friendly inhalers: focus on combination ipratropium bromide and albuterol in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2013) 0.77
Respiratory impairment and systemic inflammation in cedar asthmatics removed from exposure. PLoS One (2013) 0.75
Metabolic syndrome in patients with chronic obstructive pulmonary disease: frequency and relationship with systemic inflammation. Hippokratia (2017) 0.75
Chronic obstructive pulmonary disease: beyond the forced expiratory manoeuvre. Respiration (2008) 0.75
Cardiac injury in patients with COPD presenting with dyspnea: a pilot study. Int J Chron Obstruct Pulmon Dis (2010) 0.75
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2012) 22.96
Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med (2011) 4.16
Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. N Engl J Med (2014) 3.51
The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 3.36
Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest (2008) 2.93
Club cell protein 16 and disease progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 2.82
COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women. Eur Respir J (2013) 2.81
The relationship between lung inflammation and cardiovascular disease. Am J Respir Crit Care Med (2012) 2.54
Contemporary management of acute exacerbations of COPD: a systematic review and metaanalysis. Chest (2008) 2.41
Why do some countries publish more than others? An international comparison of research funding, English proficiency and publication output in highly ranked general medical journals. Eur J Epidemiol (2004) 2.34
The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med (2002) 2.26
Vascular risk in chronic obstructive pulmonary disease: role of inflammation and other mediators. Can J Cardiol (2012) 2.22
Lung eQTLs to help reveal the molecular underpinnings of asthma. PLoS Genet (2012) 2.09
The obesity paradox in patients with peripheral arterial disease. Chest (2008) 2.09
Inhaled corticosteroids for chronic obstructive pulmonary disease. BMJ (2012) 2.04
The growing burden of chronic obstructive pulmonary disease and lung cancer in women: examining sex differences in cigarette smoke metabolism. Am J Respir Crit Care Med (2007) 2.04
Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med (2007) 2.04
The interactions between cigarette smoking and reduced lung function on systemic inflammation. Chest (2005) 1.91
Estimation of cancer mortality associated with repetitive computed tomography scanning. Am J Respir Crit Care Med (2005) 1.88
Late intervention with a myeloperoxidase inhibitor stops progression of experimental chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 1.80
A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo. Chest (2007) 1.79
Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection. J Clin Oncol (2009) 1.68
Everything prevents emphysema: are animal models of cigarette smoke-induced chronic obstructive pulmonary disease any use? Am J Respir Cell Mol Biol (2011) 1.67
Airway wall thickness assessed using computed tomography and optical coherence tomography. Am J Respir Crit Care Med (2008) 1.64
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
Molecular signature of smoking in human lung tissues. Cancer Res (2012) 1.50
The complex relationship of serum adiponectin to COPD outcomes COPD and adiponectin. Chest (2012) 1.50
Statins reduce ambient particulate matter-induced lung inflammation by promoting the clearance of particulate matter, < 10 μm from lung tissues. Chest (2013) 1.46
Novel genes for airway wall thickness identified with combined genome-wide association and expression analyses. Am J Respir Crit Care Med (2015) 1.44
Novel properties of statins: suppression of the systemic and bone marrow responses induced by exposure to ambient particulate matter (PM(10)) air pollution. Am J Physiol Lung Cell Mol Physiol (2012) 1.44
Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res (2006) 1.44
Integrative approach to quality assessment of medical journals using impact factor, eigenfactor, and article influence scores. PLoS One (2010) 1.39
Particulate matter exposure induces persistent lung inflammation and endothelial dysfunction. Am J Physiol Lung Cell Mol Physiol (2008) 1.38
The airway epithelium: more than just a structural barrier. Ther Adv Respir Dis (2011) 1.30
Acute exacerbation of chronic obstructive pulmonary disease: influence of social factors in determining length of hospital stay and readmission rates. Can Respir J (2008) 1.28
New and current clinical imaging techniques to study chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 1.23
Marijuana and chronic obstructive lung disease: a population-based study. CMAJ (2009) 1.19
The airway epithelium nucleotide-binding domain and leucine-rich repeat protein 3 inflammasome is activated by urban particulate matter. J Allergy Clin Immunol (2012) 1.17
Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis. Am J Respir Crit Care Med (2008) 1.16
The role of female hormones on lung function in chronic lung diseases. BMC Womens Health (2011) 1.16
Statin reverses smoke-induced pulmonary hypertension and prevents emphysema but not airway remodeling. Am J Respir Crit Care Med (2010) 1.16
The relationship between telomere length and mortality in chronic obstructive pulmonary disease (COPD). PLoS One (2012) 1.12
Management of asthma among community-based primary care physicians. J Asthma (2005) 1.12
Steroids for treatment of COPD exacerbations: less is clearly more. JAMA (2013) 1.12
Incremental value of pulmonary function and sputum DNA image cytometry in lung cancer risk prediction. Cancer Prev Res (Phila) (2011) 1.10
Particulate matter induces translocation of IL-6 from the lung to the systemic circulation. Am J Respir Cell Mol Biol (2010) 1.10
Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the need for longitudinal observational studies in COPD. COPD (2012) 1.04
Effects of inhaled corticosteroids on airway inflammation in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis (2012) 1.03
Refining susceptibility loci of chronic obstructive pulmonary disease with lung eqtls. PLoS One (2013) 1.02
Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysis. BMC Pulm Med (2005) 1.01
Acute lung injury induces cardiovascular dysfunction: effects of IL-6 and budesonide/formoterol. Am J Respir Cell Mol Biol (2010) 1.01
Systematic review of blood biomarkers in cystic fibrosis pulmonary exacerbations. Chest (2013) 1.01
Interleukin-6: a red herring or a real catch in COPD? Chest (2008) 1.00
Development and validation of a prognostic index for health outcomes in chronic obstructive pulmonary disease. Arch Intern Med (2008) 0.97
Pharmacotherapy in pulmonary arterial hypertension: a systematic review and meta-analysis. Respir Res (2010) 0.97
Serum surfactant protein D during acute exacerbations of chronic obstructive pulmonary disease. Dis Markers (2009) 0.97
Economic evaluation of a community-based pulmonary rehabilitation program for chronic obstructive pulmonary disease. Lung (2004) 0.96
Telomere length and chronic obstructive pulmonary disease: evidence of accelerated aging. J Am Geriatr Soc (2009) 0.95
Is the aging process accelerated in chronic obstructive pulmonary disease? Curr Opin Pulm Med (2011) 0.94
Sex-related differences in serum cotinine concentrations in daily cigarette smokers. Nicotine Tob Res (2008) 0.93
Epidemic of lung cancer in patients with HIV infection. Chest (2013) 0.92
The influence of gender on the effects of aspirin in preventing myocardial infarction. BMC Med (2007) 0.92
Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am J Surg Pathol (2009) 0.91
DNA methylation is globally disrupted and associated with expression changes in chronic obstructive pulmonary disease small airways. Am J Respir Cell Mol Biol (2014) 0.91
Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease. Am J Cardiol (2008) 0.91
The determinants of poor respiratory health status in adults living with human immunodeficiency virus infection. AIDS Patient Care STDS (2014) 0.90
Using pulmonary imaging to move chronic obstructive pulmonary disease beyond FEV1. Am J Respir Crit Care Med (2014) 0.90
Contemporary management of chronic obstructive pulmonary disease: clinical applications. JAMA (2003) 0.89
Bronchodilator responsiveness and reported respiratory symptoms in an adult population. PLoS One (2013) 0.89
Genome-wide study identifies two loci associated with lung function decline in mild to moderate COPD. Hum Genet (2012) 0.88
Endotoxin-induced translocation of interleukin-6 from lungs to the systemic circulation. Innate Immun (2009) 0.88
Association of COPD with carotid wall intima-media thickness in vascular surgery patients. Respir Med (2009) 0.88
Epidural analgesia is associated with improved health outcomes of surgical patients with chronic obstructive pulmonary disease. Anesthesiology (2011) 0.87
Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality. Eur Heart J (2011) 0.87
Beta-blockers and health-related quality of life in patients with peripheral arterial disease and COPD. Int J Chron Obstruct Pulmon Dis (2009) 0.87
TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial. Thorax (2012) 0.86
Chronic obstructive pulmonary disease and cardiovascular diseases: a "vulnerable" relationship. Am J Respir Crit Care Med (2013) 0.86
Pathobiologic mechanisms of chronic obstructive pulmonary disease. Med Clin North Am (2012) 0.86
Ten-Year Trends in Direct Costs of COPD: A Population-Based Study. Chest (2015) 0.86
Emerging drugs for the treatment of chronic obstructive pulmonary disease. Expert Opin Emerg Drugs (2006) 0.85
Integrating lung and plasma expression of pneumo-proteins in developing biomarkers in COPD: a case study of surfactant protein D. Med Sci Monit (2010) 0.85
Statins attenuate the development of atherosclerosis and endothelial dysfunction induced by exposure to urban particulate matter (PM10). Toxicol Appl Pharmacol (2013) 0.85
Co-existence of COPD and left ventricular dysfunction in vascular surgery patients. Respir Med (2009) 0.85
Immunoglobulin G4-related lung disease: a disease with many different faces. Can Respir J (2013) 0.85
Aging does not enhance experimental cigarette smoke-induced COPD in the mouse. PLoS One (2013) 0.85
Potential role of stem cells in management of COPD. Int J Chron Obstruct Pulmon Dis (2010) 0.84
The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study. Ther Adv Respir Dis (2009) 0.84
The effects of long-acting bronchodilators on total mortality in patients with stable chronic obstructive pulmonary disease. Respir Res (2010) 0.84
Improved patient outcome with smoking cessation: when is it too late? Int J Chron Obstruct Pulmon Dis (2011) 0.84
What to do when a smoker's CT scan is "normal"?: Implications for lung cancer screening. Chest (2012) 0.83
Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a clinical benefit? Drugs (2005) 0.83
Quantification of lung surface area using computed tomography. Respir Res (2010) 0.83
Alberta Strategy to Help Manage Asthma (ASTHMA): a provincial initiative to improve outcomes for individuals with asthma. Healthc Q (2004) 0.83
The relationship of systemic inflammation to prior hospitalization in adult patients with cystic fibrosis. BMC Pulm Med (2012) 0.83
Relation between COPD severity and global cardiovascular risk in US adults. Chest (2012) 0.83
The costs of implementing the 1999 Canadian Asthma Consensus Guidelines recommendation of asthma education and spirometry for the family physician. Can Respir J (2004) 0.83
Biomarkers of therapeutic response in patients with chronic obstructive pulmonary disease: a critical review of the literature. Drugs (2011) 0.83
Thinning bone and inhaled corticosteroid in COPD: what to do until there is definitive proof? Chest (2009) 0.82
Qualitative and quantitative assessment of smoking-related lung disease: effect of iterative reconstruction on low-dose computed tomographic examinations. J Thorac Imaging (2014) 0.82
Biomarkers in COPD: are we there yet? Chest (2008) 0.82